1. Home
  2. >>
  3. Latest
  4. >>
  5. Experimental treatment AstraZeneca is 77% effective in preventing Covid-19

Experimental treatment AstraZeneca is 77% effective in preventing Covid-19



Experimental treatment AstraZeneca is 77% effective in preventing Covid-19


One AstraZeneca studio reveals that none of the 5,197 participants who received the drug contracted severe Covid-19. The British pharmaceutical manufacturer has therefore announced that the experimental treatment it is developing for the prevention of Covid-19 reduces by 77% the risk of developing a symptomatic form of the disease in frail patients.

In previous studies, the new antibody treatment It has not been shown to be effective in people exposed to the virus, but more recent results show that, by administering the drug before contact with the virus, the results are encouraging. In a note, AstraZeneca explains that, in these cases, the risk of developing a symptomatic form of the disease caused by SARS-CoV-2 is reduced by 77%, with no serious cases or deaths.

  Corals do not recover quickly after their bleaching

I study

The results already come from phase 3 of the clinical trials, aimed at evaluate the safety and efficacy of the treatmentwhich are underway in Spain, France, Belgium, the United Kingdom and the United States and involved 5,197 participants, 75% of those with comorbidities.

“With these formidable results, AZD7442 (code name of the treatment) could be an important tool in our arsenal to help people who might benefit from more than one vaccine regain a normal life,” said a leader and professor of the trial in the United States. United States, Myron Levin.

In the same sense, AstraZeneca underlines theimportance of treatment, which is administered intramuscularly as a complementary protection to vaccines. AstraZeneca also adds that it will send a dossier to health authorities, in order to obtain authorization for emergency use or validation under certain treatment conditions, the development of which is funded by the US government.